Trends in health care of patients with vasculitides, including giant cell arteritis, Takayasu arteritis, ANCA-associated vasculitis and Behçet's disease: cross-sectional data of the German National Database 2007-2021.
Behçet’s disease
Giant cell arteritis
Granulomatosis with polyangiitis
Health care
Microscopic polyangiitis
Takayasu arteritis
Journal
Rheumatology international
ISSN: 1437-160X
Titre abrégé: Rheumatol Int
Pays: Germany
ID NLM: 8206885
Informations de publication
Date de publication:
05 Jan 2024
05 Jan 2024
Historique:
received:
20
10
2023
accepted:
08
11
2023
medline:
5
1
2024
pubmed:
5
1
2024
entrez:
5
1
2024
Statut:
aheadofprint
Résumé
The aim of this study is to present the current care situation of patients with giant cell arteritis (GCA), Takayasu arteritis (TAK), ANCA-associated vasculitis (AAV) and Behçet's disease (BD). Trends over the last 15 years will reflect improvements and remaining deficits in the management of vasculitides. Consecutive cross-sectional data from patients with vasculitides from the German National Database (NDB) of the Collaborative Arthritis Centres between 2007 and 2021 were included. Medication, physician- and patient-reported outcomes on disease activity and disease burden, inpatient stays and occupational participation are compared for different vasculitis entities and over time. Employment rates were compared to German population rates. Between 502 and 854 vasculitis patients were annually documented. GCA and AAV were the most common vasculitides. Median disease duration ranged from 2 to 16 years. Over the years, glucocorticoids decreased in proportion and dose, most markedly in GCA and TAK, while biologic therapies increased up to 27%. Physicians rated disease activity as low for the vast majority of patients, while patients-reported moderate outcomes in many dimensions. PROs remained largely unchanged. The proportion of employed patients (< 65 years) increased from 47 to 57%. In recent years, biologics are increasingly used in patients with vasculitides, while glucocorticoids decreased significantly. PRO's have not improved. Work participation increased but remains lower than that in the German population.
Identifiants
pubmed: 38180499
doi: 10.1007/s00296-023-05508-x
pii: 10.1007/s00296-023-05508-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2023. The Author(s).
Références
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum 65(1):1–11. https://doi.org/10.1002/art.37715
doi: 10.1002/art.37715
pubmed: 23045170
Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Watts RA, Merkel PA, Luqmani RA, Group DS (2022) 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis 81(12):1647–1653. https://doi.org/10.1136/ard-2022-223480
doi: 10.1136/ard-2022-223480
pubmed: 36351706
Grayson PC, Ponte C, Suppiah R, Robson JC, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Danda D, Luqmani RA, Watts RA, Merkel PA, Group DS (2022) 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Ann Rheum Dis 81(12):1654–1660. https://doi.org/10.1136/ard-2022-223482
doi: 10.1136/ard-2022-223482
pubmed: 36351705
Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, Khalid S, Hutchings A, Luqmani RA, Watts RA, Merkel PA, Group DS (2022) 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis. Arthritis Rheumatol 74(3):386–392. https://doi.org/10.1002/art.41982
doi: 10.1002/art.41982
pubmed: 35106968
Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A, Khalid S, Hutchings A, Watts RA, Merkel PA, Luqmani RA, Investigators D (2022) 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis 81(3):315–320. https://doi.org/10.1136/annrheumdis-2021-221795
doi: 10.1136/annrheumdis-2021-221795
pubmed: 35110333
Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, Judge A, Hutchings A, Merkel PA, Luqmani RA, Watts RA, Dcvas I (2022) 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis 81(3):321–326. https://doi.org/10.1136/annrheumdis-2021-221796
doi: 10.1136/annrheumdis-2021-221796
pubmed: 35110332
Emmi G, Vaglio A (2023) The new look of classification criteria for systemic vasculitis. Nat Rev Rheumatol 19(4):198–199. https://doi.org/10.1038/s41584-023-00933-5
doi: 10.1038/s41584-023-00933-5
pubmed: 36829067
Sharma A, Mohammad AJ, Turesson C (2020) Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review. Semin Arthritis Rheum 50(5):1040–1048. https://doi.org/10.1016/j.semarthrit.2020.07.005
doi: 10.1016/j.semarthrit.2020.07.005
pubmed: 32911281
Redondo-Rodriguez R, Mena-Vazquez N, Cabezas-Lucena AM, Manrique-Arija S, Mucientes A, Fernandez-Nebro A (2022) Systematic review and metaanalysis of worldwide incidence and prevalence of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis. J Clin Med. https://doi.org/10.3390/jcm11092573
doi: 10.3390/jcm11092573
pubmed: 35566698
pmcid: 9106044
Herlyn K, Buckert F, Gross WL, Reinhold-Keller E (2014) Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany. Rheumatology (Oxford) 53(5):882–889. https://doi.org/10.1093/rheumatology/ket440
doi: 10.1093/rheumatology/ket440
pubmed: 24425780
Hellmich B, Lamprecht P, Spearpoint P, Gotte D, Deichmann A, Buchholz I, Schonermark MP, Rutherford P (2021) New insights into the epidemiology of ANCA-associated vasculitides in Germany: results from a claims data study. Rheumatology (Oxford) 60(10):4868–4873. https://doi.org/10.1093/rheumatology/keaa924
doi: 10.1093/rheumatology/keaa924
pubmed: 33501936
Albrecht K, Binder S, Minden K, Poddubnyy D, Regierer AC, Strangfeld A, Callhoff J (2023) Systematic review to estimate the prevalence of inflammatory rheumatic diseases in Germany. German version. Z Rheumatol. https://doi.org/10.1007/s00393-022-01305-2
doi: 10.1007/s00393-022-01305-2
pubmed: 37280334
pmcid: 10627889
Kotter I, Krusche M (2023) Inflammatory rheumatic diseases in migrants. Inn Med (Heidelb) 64(5):426–434. https://doi.org/10.1007/s00108-023-01514-0
doi: 10.1007/s00108-023-01514-0
pubmed: 37099225
Seyahi E (2017) Takayasu arteritis: an update. Curr Opin Rheumatol 29(1):51–56. https://doi.org/10.1097/BOR.0000000000000343
doi: 10.1097/BOR.0000000000000343
pubmed: 27748689
Albrecht K, Callhoff J, Zink A (2019) Long-term trends in rheumatology care : achievements and deficits in 25 years of the German national rheumatology database. Z Rheumatol 78(Suppl 2):65–72. https://doi.org/10.1007/s00393-019-0680-1
doi: 10.1007/s00393-019-0680-1
pubmed: 31407089
Thiele K, Albrecht K, Zink A, Aringer M, Karberg K, Spathling-Mestekemper S, von Hinuber U, Callhoff J (2022) Is the rheumatoid arthritis impact of disease (RAID) score a meaningful instrument for other inflammatory rheumatic diseases? A cross-sectional analysis of data from the German National Database. RMD Open. https://doi.org/10.1136/rmdopen-2022-002342
doi: 10.1136/rmdopen-2022-002342
pubmed: 36216409
pmcid: 9486391
Redeker I, Hoffmann F, Callhoff J, Haibel H, Sieper J, Zink A, Poddubnyy D (2018) Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data. Ann Rheum Dis 77(7):1017–1024. https://doi.org/10.1136/annrheumdis-2017-212629
doi: 10.1136/annrheumdis-2017-212629
pubmed: 29525776
Statistisches Bundesamt d (2023) Erwerbstätigenquoten 1991 bis 2022. http https://www.destatis.de/DE/Themen/Arbeit/Arbeitsmarkt/Erwerbstaetigkeit/Tabellen/erwerbstaetigenquoten-gebietsstand-geschlecht-altergruppe-mikrozensus.html . Accessed 26 Apr 2023.
Gisslander K, Rutherford M, Aslett L, Basu N, Dradin F, Hederman L, Hruskova Z, Kardaoui H, Lamprecht P, Licholai S, Musial J, O’Sullivan D, Puechal X, Scott J, Segelmark M, Straka R, Terrier B, Tesar V, Tesi M, Vaglio A, Wandrei D, White A, Wojcik K, Yaman B, Little MA, Mohammad AJ, consortium F (2023) Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated querying. Ann Rheum Dis. https://doi.org/10.1136/ard-2023-224571
doi: 10.1136/ard-2023-224571
Goel R, Chandan JS, Thayakaran R, Adderley NJ, Nirantharakumar K, Harper L (2021) Cardiovascular and renal morbidity in Takayasu arteritis: a population-based retrospective cohort study from the United Kingdom. Arthritis Rheumatol 73(3):504–511. https://doi.org/10.1002/art.41529
doi: 10.1002/art.41529
pubmed: 32969145
Monti S, Milanesi A, Klersy C, Tomelleri A, Dagna L, Campochiaro C, Farina N, Muratore F, Galli E, Marvisi C, Bond M, Berti A, Bortolotti R, Padoan R, Schiavon F, Felicetti M, Nannini C, Cantini F, Giollo A, Rossini M, Conticini E, Frediani B, Conti F, Priori R, Sebastiani M, Cassone G, Quartuccio L, Treppo E, Bettio S, Hoxha A, Lovisotto M, Emmi G, Mattioli I, Leccese P, Caporali R, Argolini LM, Foti R, Visalli E, Colaci M, Salvarani C, Montecucco C, Italian Society of Rheumatology Vasculitis Study G (2023) Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients. Ann Rheum Dis. https://doi.org/10.1136/ard-2023-223895
doi: 10.1136/ard-2023-223895
pubmed: 38050004
Jo YG, Ortiz-Fernandez L, Coit P, Yilmaz V, Yentur SP, Alibaz-Oner F, Aksu K, Erken E, Duzgun N, Keser G, Cefle A, Yazici A, Ergen A, Alpsoy E, Salvarani C, Kisacik B, Kotter I, Henes J, Cinar M, Schaefer A, Nohutcu RM, Takeuchi F, Harihara S, Kaburaki T, Messedi M, Song YW, Kasifoglu T, Martin J, Gonzalez Escribano MF, Saruhan-Direskeneli G, Direskeneli H, Sawalha AH (2022) Sex-specific analysis in Behcet’s disease reveals higher genetic risk in male patients. J Autoimmun 132:102882. https://doi.org/10.1016/j.jaut.2022.102882
doi: 10.1016/j.jaut.2022.102882
pubmed: 35987173
pmcid: 10614427
Rohde M, Kernder A, Acar H, Dusing C, Fischer-Betz R, Haase I, Mucke J, Sander O, Richter J, Filla T, Schneider M, Chehab G (2023) Determinants of patient and physician global assessments of disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis. Front Med (Lausanne) 10:1107148. https://doi.org/10.3389/fmed.2023.1107148
doi: 10.3389/fmed.2023.1107148
pubmed: 36844213
Holle JU, Gross WL, Latza U, Nolle B, Ambrosch P, Heller M, Fertmann R, Reinhold-Keller E (2011) Improved outcome in 445 patients with Wegener’s granulomatosis in a German vasculitis center over four decades. Arthritis Rheum 63(1):257–266. https://doi.org/10.1002/art.27763
doi: 10.1002/art.27763
pubmed: 20862686
Berti A, Cornec D, Crowson CS, Specks U, Matteson EL (2017) The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in Olmsted County, Minnesota: a twenty-year US population-based study. Arthritis Rheumatol 69(12):2338–2350. https://doi.org/10.1002/art.40313
doi: 10.1002/art.40313
pubmed: 28881446
pmcid: 5711593
Sadeghi A, Rostami M, Amraei G, Davatchi F, Shahram F, Karimi Moghaddam A, Karimi Moghaddam Z, Zeraatchi A (2023) Clinical manifestations of Behcet’s disease: a retrospective cross-sectional study. Mediterr J Rheumatol 34(1):53–60. https://doi.org/10.31138/mjr.34.1.53
doi: 10.31138/mjr.34.1.53
pubmed: 37223587
pmcid: 10201098
Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, Hatemi G, Hollinger N, Mahr A, Mollan SP, Mukhtyar C, Ponte C, Salvarani C, Sivakumar R, Tian X, Tomasson G, Turesson C, Schmidt W, Villiger PM, Watts R, Young C, Luqmani RA (2020) 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 79(1):19–30. https://doi.org/10.1136/annrheumdis-2019-215672
doi: 10.1136/annrheumdis-2019-215672
pubmed: 31270110
Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, Holle JU, Hollinger N, Karadag O, Kronbichler A, Little MA, Luqmani RA, Mahr A, Merkel PA, Mohammad AJ, Monti S, Mukhtyar CB, Musial J, Price-Kuehne F, Segelmark M, Teng YKO, Terrier B, Tomasson G, Vaglio A, Vassilopoulos D, Verhoeven P, Jayne D (2023) EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. https://doi.org/10.1136/ard-2022-223764
doi: 10.1136/ard-2022-223764
Hatemi G, Mahr A, Takeno M, Kim D, Melikoglu M, Cheng S, McCue S, Paris M, Chen M, Yazici Y (2022) Impact of apremilast on quality of life in Behcet’s syndrome: analysis of the phase 3 RELIEF study. RMD Open. https://doi.org/10.1136/rmdopen-2022-002235
doi: 10.1136/rmdopen-2022-002235
pubmed: 35798511
pmcid: 9263903
Moosig F, Bremer JP, Hellmich B, Holle JU, Holl-Ulrich K, Laudien M, Matthis C, Metzler C, Nolle B, Richardt G, Gross WL (2013) A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis 72(6):1011–1017. https://doi.org/10.1136/annrheumdis-2012-201531
doi: 10.1136/annrheumdis-2012-201531
pubmed: 22887848
Schirmer JH, Wright MN, Vonthein R, Herrmann K, Nolle B, Both M, Henes FO, Arlt A, Gross WL, Schinke S, Reinhold-Keller E, Moosig F, Holle JU (2016) Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort. Rheumatology (Oxford) 55(1):71–79. https://doi.org/10.1093/rheumatology/kev286
doi: 10.1093/rheumatology/kev286
pubmed: 26297628
Iking-Konert C, Wallmeier P, Arnold S, Adler S, de Groot K, Hellmich B, Hoyer BF, Holl-Ulrich K, Ihorst G, Kaufmann M, Kotter I, Muller-Ladner U, Magnus T, Rech J, Schubach F, Schulze-Koops H, Venhoff N, Wiech T, Villiger P, Lamprecht P (2021) The Joint Vasculitis Registry in German-speaking countries (GeVas) - a prospective, multicenter registry for the follow-up of long-term outcomes in vasculitis. BMC Rheumatol 5(1):40. https://doi.org/10.1186/s41927-021-00206-2
doi: 10.1186/s41927-021-00206-2
pubmed: 34330340
pmcid: 8325211
Wallmeier Pass F et al. (2022) Das Gemeinsame Vaskulitis-Register im deutschsprachigen Raum (GeVas) – eine Subgruppenanalyse der 131 RZA-Patienten. Paper presented at the DGRh Berlin
Barton JL, Imboden J, Graf J, Glidden D, Yelin EH, Schillinger D (2010) Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis. Arthritis Care Res (Hoboken) 62(6):857–864. https://doi.org/10.1002/acr.20132
doi: 10.1002/acr.20132
pubmed: 20535797
Castrejon I, Yazici Y, Samuels J, Luta G, Pincus T (2014) Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases: association with 5 scores on a Multidimensional Health Assessment Questionnaire (MDHAQ) that are not found on the Health Assessment Questionnaire (HAQ). Arthritis Care Res (Hoboken) 66(6):934–942. https://doi.org/10.1002/acr.22237
doi: 10.1002/acr.22237
pubmed: 24302706
Hurtado-Arias JJ, Ramirez-Mulhern I, Gonzalez-Martinez C, Merayo-Chalico J, Barrera-Vargas A, Hinojosa-Azaola A (2023) Patient-reported outcomes in ANCA-associated vasculitis: a cross-sectional study to explore the interactions between patients’ and physicians’ perspectives. Rheumatol Int 43(5):933–940. https://doi.org/10.1007/s00296-023-05288-4
doi: 10.1007/s00296-023-05288-4
pubmed: 36814035
pmcid: 9946285
Aydin SZ, Robson JC, Sreih AG, Hill C, Alibaz-Oner F, Mackie S, Beard S, Gul A, Hatemi G, Kermani TA, Mahr A, Meara A, Milman N, Shea B, Tomasson G, Tugwell P, Direskeneli H, Merkel PA (2019) Update on outcome measure development in large-vessel vasculitis: report from OMERACT 2018. J Rheumatol 46(9):1198–1201. https://doi.org/10.3899/jrheum.181072
doi: 10.3899/jrheum.181072
pubmed: 30877212
pmcid: 7254610
Thiele K, Albrecht K, Kopplin N, Callhoff J (2022) Deutsches Rheuma Forschungszentrum (DRFZ) Programmbereich Epidemiologie und Versorgungsforschung. Standardpräsentation 2020, Daten aus der Kerndokumentation. https://refubium.fu-berlin.de/handle/fub188/36566 , Zugriff am 21 June 2023.
Saur SJ, Schlogl A, Schmalen T, Krittian S, Pecher AC, Henes M, Xenitidis T, Henes J (2022) Sexual dysfunction and depression in Behcet’s disease in comparison to healthy controls. Rheumatol Int 42(1):121–126. https://doi.org/10.1007/s00296-021-05000-4
doi: 10.1007/s00296-021-05000-4
pubmed: 34581839